SMMT: Summit Therapeutics Inc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 501.52
Enterprise Value ($M) 398.13
Book Value ($M) 64.41
Book Value / Share 0.66
Price / Book 7.79
NCAV ($M) 95.39
NCAV / Share 0.98
Price / NCAV 5.26

Profitability (mra)
Return on Invested Capital (ROIC) -1.10
Return on Assets (ROA) -1.29
Return on Equity (ROE) -1.99

Liquidity (mrq)
Quick Ratio 5.55
Current Ratio 5.55

Balance Sheet (mrq) ($M)
Current Assets 121.48
Assets 145.52
Liabilities 26.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-25 13D/A Zanganeh Maky 6.58 0.06
11-10 13D/A Duggan Robert W 69.94 7.76

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-05-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-03-31 10-K Annual Report – 10-K
2020-11-16 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-10-19 31,572 107,772 29.30
2021-10-18 17,660 128,659 13.73
2021-10-15 20,218 61,326 32.97
2021-10-14 15,128 58,443 25.89

(click for more detail)

Similar Companies
SLN – Silence Therapeutics Plc American Depository Share SLRX – Salarius Pharmaceuticals Inc
SLS – Sellas Life Sciences Group Inc SNDL – Sundial Growers Inc
SNDX – Syndax Pharmaceuticals Inc


Financial data and stock pages provided by
Fintel.io